{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:03:04Z","timestamp":1785250984749,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.euros.2025.10.018","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:21:46Z","timestamp":1763554906000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Radical Prostatectomy Combined with Prostate Specific Membrane Antigen\u2013radioguided Lymph Node Dissection is Associated with Longer Treatment-free Survival for Patients with Primary Lymph Node\u2013positive Prostate Cancer"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-9156","authenticated-orcid":false,"given":"Philipp","family":"Korn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Lischewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Staehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen E.","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5754-0628","authenticated-orcid":false,"given":"Matthias M.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2025.10.018_b0005","series-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer","author":"Cornford","year":"2025"},{"key":"10.1016\/j.euros.2025.10.018_b0010","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2967\/jnumed.124.269007","article-title":"Imaging efficacy of [18F]CTT1057 PET for the detection of PSMA-positive tumors using histopathology as standard of truth: results from the GuideView phase 2\/3 prospective multicenter study","volume":"66","author":"Iagaru","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2025.10.018_b0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/JU.0000000000001698","article-title":"A phase 2\/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET\/CT with 18F-DCFPyL in prostate cancer patients (OSPREY)","volume":"206","author":"Pienta","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eururo.2023.06.018","article-title":"Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate- to very-high-risk prostate cancer: results from a phase 3, prospective, multicentre study (LIGHTHOUSE)","volume":"84","author":"Surasi","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2015.04.034","article-title":"Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer","volume":"68","author":"Maurer","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2018.10.041","article-title":"Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review","volume":"76","author":"Ploussard","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.euo.2024.04.019","article-title":"Biochemical response of <0.1\u00a0ng\/ml predicts therapy-free survival of prostate cancer patients following prostate-specific membrane antigen-targeted salvage surgery","volume":"8","author":"Knipper","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.10.018_b0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2022.06.002","volume":"82","author":"Gandaglia","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2967\/jnumed.123.266495","article-title":"Prostate-specific membrane antigen-targeted radioguided pelvic lymph node dissection in newly diagnosed prostate cancer patients with a suspicion of locoregional lymph node metastases: the DETECT trial","volume":"65","author":"Schilham","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2025.10.018_b0050","first-page":"1659","article-title":"Robot-assisted prostate-specific membrane antigen\u2013radioguided surgery in primary diagnosed prostate cancer","volume":"63","author":"Gondoputro","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2025.10.018_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.euo.2022.12.001","article-title":"Prostate-specific membrane antigen-radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases","volume":"6","author":"Lunger","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.10.018_b0060","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1007\/s00259-024-06789-5","article-title":"Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study","volume":"51","author":"Quarta","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2025.10.018_b0065","unstructured":"Greifer N. MatchIt: getting started. The Comprehensive R Network; 2025. https:\/\/cran.r-project.org\/web\/packages\/MatchIt\/vignettes\/MatchIt.html."},{"key":"10.1016\/j.euros.2025.10.018_b0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2022.05.031","article-title":"Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via prostate-specific membrane antigen\u2013radioguided surgery","volume":"83","author":"Knipper","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12149-022-01741-9","article-title":"99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients","volume":"36","author":"Y\u0131lmaz","year":"2022","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.euros.2025.10.018_b0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2019.01.048","article-title":"Persistent prostate-specific antigen after radical prostatectomy and its impact on oncologic outcomes","volume":"76","author":"Preisser","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eururo.2017.11.024","article-title":"Performance of a prostate cancer genomic classifier in predicting metastasis in men with prostate-specific antigen persistence postprostatectomy","volume":"74","author":"Spratt","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eururo.2013.03.053","article-title":"Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy","volume":"65","author":"Touijer","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2008.05.023","article-title":"Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy","volume":"54","author":"Schumacher","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0100","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/JU.0000000000001596","volume":"205","author":"Amiel","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0105","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2967\/jnumed.123.265556","article-title":"The diagnostic value of the sentinel node procedure to detect occult lymph node metastases in PSMA PET\/CT node\u2013negative prostate cancer patients","volume":"64","author":"Duin","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2025.10.018_b0110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/JU.0000000000002803","article-title":"Neoadjuvant novel hormonal therapy followed by prostatectomy versus up-front prostatectomy for high-risk prostate cancer: a comparative analysis","volume":"208","author":"Ravi","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.10.018_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2023.08.026","article-title":"Administering [177Lu]Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localised prostate cancer (LuTectomy): a single-centre, single-arm, phase 1\/2 study","volume":"85","author":"Eapen","year":"2024","journal-title":"Eur Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325019494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325019494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:03:21Z","timestamp":1766131401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168325019494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"alternative-id":["S2666168325019494"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2025.10.018","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radical Prostatectomy Combined with Prostate Specific Membrane Antigen\u2013radioguided Lymph Node Dissection is Associated with Longer Treatment-free Survival for Patients with Primary Lymph Node\u2013positive Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2025.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}